Fundraising Fox

Rivus Pharmaceuticals, Inc.

Charlottesville, US · Founded 2019 · Delaware corporation · 2 known investors

Biotech

Founders & leadership

AC
Allen CunninghamExecutive Officer, Director
NH
Nancy HargreavesExecutive Officer
JD
Jayson DallasExecutive Officer, Director
SK
Shaharyar KhanExecutive Officer, Director
PE
Patrick EnrightDirector
FD
Francesco De RubertisDirector
DD
Derek DiRoccoDirector
IS
Ian SmithDirector
RW
Rick WinninghamDirector

Investors · 2

MedicxireportedLondonvia Francesco De Rubertis · board
RA CapitalreportedBostonvia Derek DiRocco · board

Reported raises · per SEC filings

Form D private placements
▶$57MraisedJan 2025 · 7 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert SchottExecutive Officer
  • Shaharyar KhanExecutive Officer, Director
  • Rick WinninghamDirector
  • Allen CunninghamExecutive Officer, Director
  • Jayson DallasExecutive Officer, Director
  • Tom O'NeilExecutive Officer
  • Derek DiRoccoDirector
  • Ian SmithDirector
  • Erin LavelleDirector
  • Francesco De RubertisDirector
Offering amount
$57M
Amount sold
$57M
First sale
Jan 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$66MraisedSep 2024 · 7 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Ian SmithDirector
  • Allen CunninghamExecutive Officer, Director
  • Francesco De RubertisDirector
  • Derek DiRoccoDirector
  • Rick WinninghamDirector
  • Shaharyar KhanExecutive Officer, Director
  • Jayson DallasExecutive Officer, Director
  • Nancy HargreavesExecutive Officer
Offering amount
$66M
Amount sold
$66M
First sale
Aug 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$66MraisedSep 2024 · 7 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Ian SmithDirector
  • Allen CunninghamExecutive Officer, Director
  • Francesco De RubertisDirector
  • Rick WinninghamDirector
  • Nancy HargreavesExecutive Officer
  • Jayson DallasExecutive Officer, Director
  • Derek DiRoccoDirector
  • Shaharyar KhanExecutive Officer, Director
Offering amount
$66M
Amount sold
$66M
First sale
Aug 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$34.5MraisedOct 2021 · 4 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Shaharyar KhanExecutive Officer, Director
  • Patrick EnrightDirector
  • Jayson DallasDirector
  • Allen CunninghamExecutive Officer, Director
  • Francesco De RubertisDirector
Offering amount
$35M
Amount sold
$34.5M
First sale
Mar 2019
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.